| Quantity | Price per inhaler | You save | Total price | |
|---|---|---|---|---|
| 2 | $90.50 | - | $181.00 | |
| 4 | $75.50 | $60.00 | $302.00 | |
| 6 | $69.50 | $126.00 | $417.00 |
Your order is securely packed and usually ships within 24 hours. Below is what a standard package looks like.
It is about the size of a regular letter (9.4x4.3x0.3 inches) and shows no details about what is inside.
| Shipping Method | Estimated delivery |
|---|---|
| Express Free for orders over $300.00 | Estimated delivery to the U.S.: 4-7 days |
| Standard Free for orders over $200.00 | Estimated delivery to the U.S.: 14-21 days |
| Country | Brand Names |
|---|---|
| Canada | Zenhale |
Mometasone furoate is an inhaled corticosteroid. With regular use, it reduces inflammation and sensitivity inside the airways. Formoterol fumarate is a long-acting beta2-agonist that relaxes airway muscles and helps keep the airways open between scheduled doses. Combining them in one inhaler can simplify a maintenance routine when a clinician has determined that both types of treatment are appropriate.
The fixed combination also means that the amount of each ingredient cannot be adjusted independently. A person who needs a different corticosteroid dose, a different long-acting bronchodilator, or separate adjustment of the two components may need another treatment plan. Dulera should not be added to another long-acting beta2-agonist unless a clinician has specifically reviewed the combination.
Dulera may be considered when asthma is not adequately controlled with an inhaled corticosteroid alone or when the condition already warrants treatment with both an inhaled corticosteroid and a long-acting bronchodilator. The listed 200 mcg mometasone strength is associated with treatment for patients 12 years of age and older; younger children require age-appropriate products and strengths.
Several factors can affect whether this exact inhaler is a suitable match:
These points help frame a discussion, but they do not establish that Dulera is appropriate for a particular person. A prescriber must assess asthma control, current treatment, inhaler technique, and relevant medical history.
The two ingredients do not serve identical purposes. Formoterol can begin relaxing airway muscles relatively quickly, while the full anti-inflammatory benefit of mometasone depends on continued, regular use. Even though formoterol can have a rapid onset, Dulera is not labeled as a rescue inhaler and should not replace the acute-relief medicine prescribed for sudden symptoms.
This distinction matters when evaluating the product. Dulera is intended to support ongoing control, such as fewer recurring symptoms and improved breathing stability over time. It is not meant to produce guaranteed or immediate relief from every symptom. Missing scheduled doses can reduce maintenance coverage, while taking extra doses without clinical direction can increase the risk of adverse effects.
Dulera is generally used twice daily, in the morning and evening, according to the prescribed directions. The exact number of actuations must come from the applicable product label and prescriber. Do not change the dose or frequency based only on symptom severity.
Useful administration and care steps include:
Store the inhaler at 68°F to 77°F; permitted temperature excursions are 59°F to 86°F. Keep it with the mouthpiece down. The contents are under pressure, so do not puncture or incinerate the canister and do not expose it to temperatures above 120°F.
We offer the listed 5 mcg/200 mcg product in quantities of two, four, or six inhalers. The strength remains the same across these options; only the number of inhalers changes. The appropriate quantity depends on the prescribed directions, the number of actuations in each supplied inhaler, and when the treatment is due for clinical review.
A larger quantity should not be treated as permission to extend treatment, increase the dose, or postpone necessary follow-up. Before selecting a quantity, verify the exact product strength and check that the anticipated supply aligns with the prescribed regimen. We do not state a fixed number of treatment days because that cannot be calculated reliably from package quantity alone.
Some bronchodilator effect may occur early, but improvement in overall asthma control can take longer because the corticosteroid component works with consistent use. The response varies among patients, so progress should be assessed against the goals established with the prescriber rather than against a guaranteed timeline.
Increasing reliance on a rescue inhaler, nighttime awakening, activity limitation, or symptoms that are not improving can indicate that asthma is not adequately controlled. Sudden severe breathing difficulty requires urgent medical attention. Patients should not respond to worsening symptoms by taking extra Dulera unless their clinician has provided explicit instructions to do so.
Dulera can cause side effects associated with inhaled corticosteroids, long-acting beta2-agonists, or both. Common concerns can include headache, throat irritation, hoarseness, and oral thrush. Rinsing the mouth after use helps reduce local corticosteroid effects but does not eliminate every risk.
Pregnancy and breastfeeding require an individualized discussion because available human data are limited. The clinician should weigh the benefits of maintaining asthma control against potential medicine-related risks. No specific impairment of driving or operating machinery is expected, although an individual experiencing dizziness or another relevant effect should avoid those activities until it resolves.
Another medicine containing a long-acting beta2-agonist should generally not be used with Dulera because excessive exposure can increase cardiovascular and other adverse effects. Patients should provide a complete list of prescription medicines, nonprescription products, and supplements before starting treatment.
Beta-blockers can reduce the bronchodilator effect of formoterol and may trigger bronchospasm in susceptible patients. Certain diuretics can worsen changes in potassium or heart rhythm. Strong CYP3A4 inhibitors can increase systemic exposure to mometasone. Monoamine oxidase inhibitors, tricyclic antidepressants, and other medicines that affect cardiac rhythm may also require additional caution.
A history of heart rhythm problems, significant cardiovascular disease, high blood pressure, hyperthyroidism, seizures, diabetes, osteoporosis, glaucoma, cataracts, liver impairment, or recurrent infections may influence monitoring or product selection. These conditions do not all rule out treatment, but they should be reviewed before use.
Combination inhalers differ in their corticosteroid, long-acting bronchodilator, device, labeled strength, and dosing schedule. Symbicort combines budesonide with formoterol and is also supplied as a metered-dose aerosol in the United States. Advair Diskus combines fluticasone propionate with salmeterol in a dry-powder device. Breo Ellipta uses fluticasone furoate and vilanterol in a dry-powder inhaler with a once-daily maintenance schedule.
How does Dulera compare to Advair Diskus?
Feature Dulera Advair Diskus Active ingredients Mometasone and formoterol Fluticasone and salmeterol Medicine class ICS/LABA combination ICS/LABA combination Common use Asthma maintenance Asthma maintenance Dosage form Metered-dose inhalation aerosol Dry powder inhalation Available strengths 5 mcg + 200 mcg 100 mcg + 50 mcg, 250 mcg + 50 mcg, 500 mcg + 50 mcg Device type Pressurized inhaler Diskus multidose blister
How does Dulera compare to Symbicort?
Feature Dulera Symbicort Active ingredients Mometasone and formoterol Budesonide and formoterol Medicine class ICS/LABA combination ICS/LABA combination Common use Asthma maintenance Asthma maintenance Dosage form Metered-dose inhalation aerosol Inhalation powder Available strengths 5 mcg + 200 mcg 100 mcg + 6 mcg, 200 mcg + 6 mcg, 400 mcg + 6 mcg
These differences make comparisons conditional rather than absolute. A metered-dose aerosol may suit someone who can coordinate actuation and inhalation or use an appropriate spacer, while a dry-powder device requires sufficient inspiratory flow. Once-daily treatment may simplify some routines, whereas another patient may need a different ingredient or dosing approach. Product approval, strengths, and instructions also vary by market, so a brand available elsewhere should not automatically be treated as a US substitute. Our Asthma category provides another way to review relevant catalog options before discussing a change with a prescriber.
Dulera is available in the United States by prescription only and is FDA-approved for maintenance treatment of asthma within its labeled patient population. It is not approved for relief of acute bronchospasm. Our checkout process does not change those regulatory facts.
Our stated ordering policy does not require customers to submit a prescription during checkout. Our policy does not change Dulera's US prescription-only status or replace appropriate prescribing guidance. Verify the exact label, strength, and directions before using the product.
Our catalog presents the listed product in quantities of two, four, or six inhalers, with prices shown in US dollars. Before placing an order, compare the product name, dosage form, active ingredients, strength per actuation, and package quantity with the intended treatment. Confirm the package details rather than relying on the Dulera brand name alone.
We have operated since 2017, and our support team is available 24/7 by email, online chat, or phone. Pharmacist support is also available for questions about the listed product, inhaler handling, storage, or order details. Support can clarify product information but cannot diagnose asthma, select treatment for an individual, or replace directions from the prescribing clinician. No shipping speed, delivery date, insurance coverage, or reimbursement outcome should be assumed unless it is explicitly provided during the order process.
Dulera may fit a treatment plan that calls for scheduled use of mometasone furoate and formoterol fumarate in a pressurized metered-dose inhaler. The main purchase decision is not simply whether a combination maintenance inhaler is desired; it is whether this exact dosage form, ingredient combination, strength, and package quantity match the prescribed product.
Our listing identifies 5 mcg formoterol fumarate and 200 mcg mometasone furoate per actuation, matching the corresponding FDA-labeled Dulera strength. Verify the packaging before use. If the intended treatment instead calls for a different strength, another corticosteroid, a dry-powder device, or a once-daily schedule, a related combination inhaler may be a more appropriate product to discuss with the prescriber.
I found a much cheaper generic inhaler on another website. Why should I pay more through your store?
We stand behind the quality of the generic medicines we offer. We cannot verify what another seller supplies, how it is sourced or handled, or whether a lower-priced listing is truly equivalent in manufacturer, origin, and product condition. The choice is yours, but only you can decide whether the savings are worth accepting that unknown risk.
I live in Dallas, where summer heat can be intense. Can this pressurized inhaler normally travel by mail without being ruined?
A metered-dose inhaler can normally be mailed when it is properly protected from crushing, puncture, and excessive heat. Keep it within its labeled handling conditions as far as possible, and inspect the carton, canister, mouthpiece, and spray function after arrival. Do not use it if it appears damaged or may have been exposed to extreme heat.
Will the inhaler package say Dulera, or could it have a different generic or manufacturer name on it?
The exact trade name on the supplied package cannot be guaranteed. Verify the label shows formoterol fumarate plus mometasone furoate, a metered-dose inhalation aerosol, and 5 mcg formoterol fumarate plus 200 mcg mometasone furoate per actuation. If the active ingredients, strength, or dosage form do not match, do not use it before the discrepancy is checked.
My 11-year-old son has asthma. Is the 5 mcg/200 mcg inhaler the right strength for a child his age?
This higher mometasone strength is generally intended for patients age 12 and older. Children ages 5 to under 12 who are prescribed this combination use a lower mometasone strength, so the child's prescriber should confirm the appropriate inhaler and dose.
| Active ingredient | Mometasone and formoterol |
|---|---|
| Drug class | Inhaled corticosteroid and long-acting beta2-agonist combination |
| Dosage form | Metered-dose inhalation aerosol |
| Available strengths | 5 mcg formoterol fumarate + 200 mcg mometasone furoate per actuation |
| Route | Oral inhalation |
| Storage | Store at 68°F to 77°F; excursions permitted between 59°F and 86°F. Store the inhaler with the mouthpiece down. Contents are under pressure: do not puncture or incinerate, and do not expose to temperatures above 120°F. |
| ATC code | R03AK09 |
This product has 30 ratings, but only 3 written reviews so far. Share your experience and help other customers.
I'll be ordering again.
No problems at all.
I asked about delivery before ordering Dulera, and support answered clearly.
